Item 16. Form 10-K Summary.

4K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary.

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


		CVS HEALTH CORPORATION
Date:	February 7, 2024	By:	/s/ THOMAS F. COWHEY
			Thomas F. Cowhey
			Executive Vice President and Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


Signature	Title(s)	Date

/s/ FERNANDO AGUIRRE	Director	February 7, 2024
Fernando Aguirre

/s/ JEFFREY R. BALSER, M.D., Ph.D.	Director	February 7, 2024
Jeffrey R. Balser, M.D., Ph.D.

/s/ C. DAVID BROWN II	Director	February 7, 2024
C. David Brown II

/s/ JAMES D. CLARK	Senior Vice President - Controller and Chief	February 7, 2024
James D. Clark	Accounting Officer (Principal Accounting Officer)

/s/ THOMAS F. COWHEY	Executive Vice President and Chief Financial Officer	February 7, 2024
Thomas F. Cowhey	(Principal Financial Officer)

/s/ ALECIA A. DECOUDREAUX	Director	February 7, 2024
Alecia A. DeCoudreaux

/s/ NANCY-ANN M. DEPARLE	Director	February 7, 2024
Nancy-Ann M. DeParle

/s/ ROGER N. FARAH	Chair of the Board and Director	February 7, 2024
Roger N. Farah

/s/ ANNE M. FINUCANE	Director	February 7, 2024
Anne M. Finucane

/s/ J. SCOTT KIRBY	Director	February 7, 2024
J. Scott Kirby

/s/ EDWARD J. LUDWIG	Director	February 7, 2024
Edward J. Ludwig

/s/ KAREN S. LYNCH	President and Chief Executive Officer	February 7, 2024
Karen S. Lynch	(Principal Executive Officer) and Director

/s/ JEAN-PIERRE MILLON	Director	February 7, 2024
Jean-Pierre Millon

/s/ MICHAEL F. MAHONEY	Director	February 7, 2024
Michael F. Mahoney

/s/ MARY L. SCHAPIRO	Director	February 7, 2024
Mary L. Schapiro

Previous: Item 15. Exhibits, Financial Statement Schedules.